nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90AA1—larynx—esophageal cancer	0.0534	0.194	CbGeAlD
Rifabutin—HSP90B1—exocrine gland—esophageal cancer	0.0303	0.11	CbGeAlD
Rifabutin—Burkitt's lymphoma—Methotrexate—esophageal cancer	0.0292	0.166	CcSEcCtD
Rifabutin—HSP90AA1—exocrine gland—esophageal cancer	0.0222	0.0807	CbGeAlD
Rifabutin—HSP90B1—neck—esophageal cancer	0.0194	0.0705	CbGeAlD
Rifabutin—HSP90AA1—neck—esophageal cancer	0.0142	0.0516	CbGeAlD
Rifabutin—HSP90B1—epithelium—esophageal cancer	0.0132	0.048	CbGeAlD
Rifabutin—HSP90B1—bronchus—esophageal cancer	0.013	0.0472	CbGeAlD
Rifabutin—HSP90B1—smooth muscle tissue—esophageal cancer	0.0127	0.0462	CbGeAlD
Rifabutin—Rifaximin—NR1I2—esophageal cancer	0.0123	0.576	CrCbGaD
Rifabutin—HSP90B1—trachea—esophageal cancer	0.0117	0.0424	CbGeAlD
Rifabutin—White blood cell disorder—Capecitabine—esophageal cancer	0.0108	0.0616	CcSEcCtD
Rifabutin—HSP90B1—digestive system—esophageal cancer	0.01	0.0365	CbGeAlD
Rifabutin—HSP90AA1—epithelium—esophageal cancer	0.00964	0.0351	CbGeAlD
Rifabutin—HSP90AA1—bronchus—esophageal cancer	0.00949	0.0346	CbGeAlD
Rifabutin—HSP90AA1—smooth muscle tissue—esophageal cancer	0.00929	0.0338	CbGeAlD
Rifabutin—HSP90AA1—trachea—esophageal cancer	0.00852	0.031	CbGeAlD
Rifabutin—HSP90B1—lung—esophageal cancer	0.00838	0.0305	CbGeAlD
Rifabutin—Urine color abnormal—Capecitabine—esophageal cancer	0.00797	0.0453	CcSEcCtD
Rifabutin—HSP90AA1—digestive system—esophageal cancer	0.00733	0.0267	CbGeAlD
Rifabutin—HSP90AA1—lung—esophageal cancer	0.00613	0.0223	CbGeAlD
Rifabutin—HSP90B1—lymph node—esophageal cancer	0.00573	0.0208	CbGeAlD
Rifabutin—Chromaturia—Capecitabine—esophageal cancer	0.00526	0.0299	CcSEcCtD
Rifabutin—Congenital anomaly—Capecitabine—esophageal cancer	0.00494	0.0281	CcSEcCtD
Rifabutin—Developmental delay—Capecitabine—esophageal cancer	0.00494	0.0281	CcSEcCtD
Rifabutin—Rifampicin—NR1I2—esophageal cancer	0.00442	0.206	CrCbGaD
Rifabutin—HSP90AA1—lymph node—esophageal cancer	0.00419	0.0152	CbGeAlD
Rifabutin—Lymphopenia—Capecitabine—esophageal cancer	0.00367	0.0209	CcSEcCtD
Rifabutin—Platelet count decreased—Capecitabine—esophageal cancer	0.00316	0.0179	CcSEcCtD
Rifabutin—Bacterial infection—Methotrexate—esophageal cancer	0.00303	0.0172	CcSEcCtD
Rifabutin—Aphasia—Capecitabine—esophageal cancer	0.00289	0.0165	CcSEcCtD
Rifabutin—Pain—Carboplatin—esophageal cancer	0.00265	0.0151	CcSEcCtD
Rifabutin—Body temperature increased—Carboplatin—esophageal cancer	0.00245	0.0139	CcSEcCtD
Rifabutin—CYP1A2—digestive system—esophageal cancer	0.00237	0.00863	CbGeAlD
Rifabutin—Aphasia—Methotrexate—esophageal cancer	0.00215	0.0123	CcSEcCtD
Rifabutin—Chest discomfort—Capecitabine—esophageal cancer	0.00212	0.0121	CcSEcCtD
Rifabutin—Skin discolouration—Capecitabine—esophageal cancer	0.00208	0.0118	CcSEcCtD
Rifabutin—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00198	0.0113	CcSEcCtD
Rifabutin—CYP1A2—lung—esophageal cancer	0.00198	0.00721	CbGeAlD
Rifabutin—Rifampicin—ABCC2—esophageal cancer	0.00198	0.0925	CrCbGaD
Rifabutin—Rifampicin—CYP2A6—esophageal cancer	0.00196	0.0914	CrCbGaD
Rifabutin—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00188	0.0107	CcSEcCtD
Rifabutin—CYP3A4—digestive system—esophageal cancer	0.00172	0.00625	CbGeAlD
Rifabutin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00166	0.00947	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00157	0.00891	CcSEcCtD
Rifabutin—Skin discolouration—Methotrexate—esophageal cancer	0.00155	0.0088	CcSEcCtD
Rifabutin—Pancytopenia—Cisplatin—esophageal cancer	0.00152	0.00863	CcSEcCtD
Rifabutin—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00148	0.0084	CcSEcCtD
Rifabutin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00135	0.00766	CcSEcCtD
Rifabutin—Connective tissue disorder—Cisplatin—esophageal cancer	0.00126	0.00715	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00123	0.00698	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.0012	0.00684	CcSEcCtD
Rifabutin—Eye disorder—Cisplatin—esophageal cancer	0.0012	0.0068	CcSEcCtD
Rifabutin—Bronchospasm—Capecitabine—esophageal cancer	0.00116	0.00659	CcSEcCtD
Rifabutin—Immune system disorder—Cisplatin—esophageal cancer	0.00116	0.00657	CcSEcCtD
Rifabutin—Pancytopenia—Capecitabine—esophageal cancer	0.00112	0.00636	CcSEcCtD
Rifabutin—Neutropenia—Capecitabine—esophageal cancer	0.0011	0.00626	CcSEcCtD
Rifabutin—Flatulence—Cisplatin—esophageal cancer	0.0011	0.00624	CcSEcCtD
Rifabutin—Anaemia—Cisplatin—esophageal cancer	0.00103	0.00585	CcSEcCtD
Rifabutin—Jaundice—Capecitabine—esophageal cancer	0.00102	0.00582	CcSEcCtD
Rifabutin—Leukopenia—Cisplatin—esophageal cancer	0.000996	0.00567	CcSEcCtD
Rifabutin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000993	0.00565	CcSEcCtD
Rifabutin—Agranulocytosis—Capecitabine—esophageal cancer	0.00098	0.00557	CcSEcCtD
Rifabutin—Convulsion—Cisplatin—esophageal cancer	0.000964	0.00549	CcSEcCtD
Rifabutin—Myalgia—Cisplatin—esophageal cancer	0.000948	0.00539	CcSEcCtD
Rifabutin—Hepatitis—Capecitabine—esophageal cancer	0.000943	0.00536	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000941	0.00535	CcSEcCtD
Rifabutin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000926	0.00527	CcSEcCtD
Rifabutin—Thrombocytopenia—Cisplatin—esophageal cancer	0.00089	0.00506	CcSEcCtD
Rifabutin—Skin disorder—Cisplatin—esophageal cancer	0.000882	0.00502	CcSEcCtD
Rifabutin—Eye disorder—Capecitabine—esophageal cancer	0.000881	0.00501	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—esophageal cancer	0.000868	0.00494	CcSEcCtD
Rifabutin—Anorexia—Cisplatin—esophageal cancer	0.000866	0.00493	CcSEcCtD
Rifabutin—Immune system disorder—Capecitabine—esophageal cancer	0.000851	0.00484	CcSEcCtD
Rifabutin—Pancytopenia—Methotrexate—esophageal cancer	0.000833	0.00474	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000828	0.00471	CcSEcCtD
Rifabutin—Neutropenia—Methotrexate—esophageal cancer	0.00082	0.00466	CcSEcCtD
Rifabutin—Paraesthesia—Cisplatin—esophageal cancer	0.000816	0.00464	CcSEcCtD
Rifabutin—Dyspnoea—Cisplatin—esophageal cancer	0.00081	0.00461	CcSEcCtD
Rifabutin—Flatulence—Capecitabine—esophageal cancer	0.000809	0.0046	CcSEcCtD
Rifabutin—Dysgeusia—Capecitabine—esophageal cancer	0.000804	0.00457	CcSEcCtD
Rifabutin—Decreased appetite—Cisplatin—esophageal cancer	0.00079	0.00449	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000784	0.00446	CcSEcCtD
Rifabutin—Pain—Cisplatin—esophageal cancer	0.000777	0.00442	CcSEcCtD
Rifabutin—Anaemia—Capecitabine—esophageal cancer	0.000758	0.00431	CcSEcCtD
Rifabutin—Feeling abnormal—Cisplatin—esophageal cancer	0.000749	0.00426	CcSEcCtD
Rifabutin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000739	0.0042	CcSEcCtD
Rifabutin—Leukopenia—Capecitabine—esophageal cancer	0.000735	0.00418	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—esophageal cancer	0.000729	0.00415	CcSEcCtD
Rifabutin—Rifampicin—ABCB1—esophageal cancer	0.000728	0.034	CrCbGaD
Rifabutin—Body temperature increased—Cisplatin—esophageal cancer	0.000718	0.00408	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—esophageal cancer	0.000702	0.00399	CcSEcCtD
Rifabutin—Chest pain—Capecitabine—esophageal cancer	0.000699	0.00397	CcSEcCtD
Rifabutin—Myalgia—Capecitabine—esophageal cancer	0.000699	0.00397	CcSEcCtD
Rifabutin—Arthralgia—Capecitabine—esophageal cancer	0.000699	0.00397	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000694	0.00395	CcSEcCtD
Rifabutin—Confusional state—Capecitabine—esophageal cancer	0.000675	0.00384	CcSEcCtD
Rifabutin—Hypersensitivity—Cisplatin—esophageal cancer	0.000669	0.00381	CcSEcCtD
Rifabutin—Shock—Capecitabine—esophageal cancer	0.000659	0.00375	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—esophageal cancer	0.000656	0.00373	CcSEcCtD
Rifabutin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000656	0.00373	CcSEcCtD
Rifabutin—Asthenia—Cisplatin—esophageal cancer	0.000652	0.00371	CcSEcCtD
Rifabutin—Skin disorder—Capecitabine—esophageal cancer	0.000651	0.0037	CcSEcCtD
Rifabutin—Anorexia—Capecitabine—esophageal cancer	0.000638	0.00363	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—esophageal cancer	0.000634	0.00361	CcSEcCtD
Rifabutin—Diarrhoea—Cisplatin—esophageal cancer	0.000622	0.00354	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00061	0.00347	CcSEcCtD
Rifabutin—Insomnia—Capecitabine—esophageal cancer	0.000606	0.00345	CcSEcCtD
Rifabutin—Paraesthesia—Capecitabine—esophageal cancer	0.000601	0.00342	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—esophageal cancer	0.000598	0.0034	CcSEcCtD
Rifabutin—Dyspnoea—Capecitabine—esophageal cancer	0.000597	0.0034	CcSEcCtD
Rifabutin—Dyspepsia—Capecitabine—esophageal cancer	0.00059	0.00335	CcSEcCtD
Rifabutin—Decreased appetite—Capecitabine—esophageal cancer	0.000582	0.00331	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000578	0.00329	CcSEcCtD
Rifabutin—Vomiting—Cisplatin—esophageal cancer	0.000578	0.00329	CcSEcCtD
Rifabutin—Rash—Cisplatin—esophageal cancer	0.000573	0.00326	CcSEcCtD
Rifabutin—Pain—Capecitabine—esophageal cancer	0.000573	0.00326	CcSEcCtD
Rifabutin—Dermatitis—Cisplatin—esophageal cancer	0.000572	0.00326	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—esophageal cancer	0.000565	0.00321	CcSEcCtD
Rifabutin—Feeling abnormal—Capecitabine—esophageal cancer	0.000552	0.00314	CcSEcCtD
Rifabutin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000548	0.00311	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—esophageal cancer	0.000547	0.00311	CcSEcCtD
Rifabutin—Nausea—Cisplatin—esophageal cancer	0.00054	0.00307	CcSEcCtD
Rifabutin—Abdominal pain—Capecitabine—esophageal cancer	0.000529	0.00301	CcSEcCtD
Rifabutin—Body temperature increased—Capecitabine—esophageal cancer	0.000529	0.00301	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—esophageal cancer	0.000529	0.00301	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—esophageal cancer	0.00052	0.00296	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—esophageal cancer	0.00052	0.00296	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—esophageal cancer	0.00052	0.00296	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000516	0.00294	CcSEcCtD
Rifabutin—Confusional state—Methotrexate—esophageal cancer	0.000503	0.00286	CcSEcCtD
Rifabutin—Hypersensitivity—Capecitabine—esophageal cancer	0.000493	0.00281	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000488	0.00278	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—esophageal cancer	0.000484	0.00275	CcSEcCtD
Rifabutin—Asthenia—Capecitabine—esophageal cancer	0.00048	0.00273	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—esophageal cancer	0.000475	0.0027	CcSEcCtD
Rifabutin—Pruritus—Capecitabine—esophageal cancer	0.000474	0.00269	CcSEcCtD
Rifabutin—Diarrhoea—Capecitabine—esophageal cancer	0.000458	0.00261	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000454	0.00258	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—esophageal cancer	0.000451	0.00256	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—esophageal cancer	0.000448	0.00255	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—esophageal cancer	0.000444	0.00253	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—esophageal cancer	0.000439	0.0025	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—esophageal cancer	0.000433	0.00246	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00043	0.00245	CcSEcCtD
Rifabutin—Pain—Methotrexate—esophageal cancer	0.000426	0.00242	CcSEcCtD
Rifabutin—Vomiting—Capecitabine—esophageal cancer	0.000426	0.00242	CcSEcCtD
Rifabutin—Rash—Capecitabine—esophageal cancer	0.000422	0.0024	CcSEcCtD
Rifabutin—Dermatitis—Capecitabine—esophageal cancer	0.000422	0.0024	CcSEcCtD
Rifabutin—Headache—Capecitabine—esophageal cancer	0.00042	0.00239	CcSEcCtD
Rifabutin—Feeling abnormal—Methotrexate—esophageal cancer	0.000411	0.00234	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000408	0.00232	CcSEcCtD
Rifabutin—Nausea—Capecitabine—esophageal cancer	0.000398	0.00226	CcSEcCtD
Rifabutin—Body temperature increased—Methotrexate—esophageal cancer	0.000394	0.00224	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—esophageal cancer	0.000394	0.00224	CcSEcCtD
Rifabutin—Hypersensitivity—Methotrexate—esophageal cancer	0.000367	0.00209	CcSEcCtD
Rifabutin—Asthenia—Methotrexate—esophageal cancer	0.000358	0.00203	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—esophageal cancer	0.000353	0.00201	CcSEcCtD
Rifabutin—Diarrhoea—Methotrexate—esophageal cancer	0.000341	0.00194	CcSEcCtD
Rifabutin—Vomiting—Methotrexate—esophageal cancer	0.000317	0.0018	CcSEcCtD
Rifabutin—Rash—Methotrexate—esophageal cancer	0.000314	0.00179	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—esophageal cancer	0.000314	0.00179	CcSEcCtD
Rifabutin—Headache—Methotrexate—esophageal cancer	0.000312	0.00178	CcSEcCtD
Rifabutin—Nausea—Methotrexate—esophageal cancer	0.000296	0.00168	CcSEcCtD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000191	0.000361	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—WIF1—esophageal cancer	0.000191	0.000361	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—GAPDH—esophageal cancer	0.00019	0.000361	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HIST1H2BM—esophageal cancer	0.00019	0.000361	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.00019	0.000359	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP26A1—esophageal cancer	0.000186	0.000352	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALOX15—esophageal cancer	0.000181	0.000343	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—PIK3CA—esophageal cancer	0.000181	0.000342	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000179	0.00034	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000176	0.000334	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000176	0.000333	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ACTB—esophageal cancer	0.000175	0.000332	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN1A—esophageal cancer	0.000175	0.000331	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000174	0.00033	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—ERBB2—esophageal cancer	0.000173	0.000328	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.000173	0.000328	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KDR—esophageal cancer	0.000173	0.000328	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTO1—esophageal cancer	0.000173	0.000327	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TPI1—esophageal cancer	0.000173	0.000327	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTPN2—esophageal cancer	0.000171	0.000324	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.00017	0.000322	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—B2M—esophageal cancer	0.000169	0.000321	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MET—esophageal cancer	0.000169	0.000321	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PIK3CA—esophageal cancer	0.000168	0.000319	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—XIAP—esophageal cancer	0.000168	0.000319	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—BCL2—esophageal cancer	0.000168	0.000318	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PIK3CA—esophageal cancer	0.000166	0.000315	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—EP300—esophageal cancer	0.000166	0.000315	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALDOB—esophageal cancer	0.000166	0.000314	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	0.000165	0.000312	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PFN1—esophageal cancer	0.000165	0.000312	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000164	0.000311	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ERBB2—esophageal cancer	0.000163	0.000309	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NOTCH1—esophageal cancer	0.000163	0.000309	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	0.000163	0.000309	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000162	0.000306	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PSME2—esophageal cancer	0.00016	0.000303	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PSME1—esophageal cancer	0.00016	0.000303	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GAPDH—esophageal cancer	0.000159	0.000302	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000159	0.000301	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HSPA5—esophageal cancer	0.000159	0.0003	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CRABP1—esophageal cancer	0.000158	0.000299	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—B2M—esophageal cancer	0.000156	0.000296	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.000154	0.000292	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CALR—esophageal cancer	0.000154	0.000291	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—TLR4—esophageal cancer	0.000153	0.000289	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000152	0.000289	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GNG7—esophageal cancer	0.00015	0.000285	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ENO1—esophageal cancer	0.00015	0.000284	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000149	0.000281	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FBXW7—esophageal cancer	0.000149	0.000281	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ELMO1—esophageal cancer	0.000148	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PSME2—esophageal cancer	0.000148	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PSME1—esophageal cancer	0.000148	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CREBBP—esophageal cancer	0.000148	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKAP13—esophageal cancer	0.000145	0.000274	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HMGB1—esophageal cancer	0.000142	0.000269	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CALR—esophageal cancer	0.000142	0.000269	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000141	0.000268	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000141	0.000268	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALDH2—esophageal cancer	0.000141	0.000267	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CDKN1A—esophageal cancer	0.000139	0.000264	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FBXW7—esophageal cancer	0.000137	0.00026	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—RB1—esophageal cancer	0.000136	0.000258	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTT1—esophageal cancer	0.000134	0.000254	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000134	0.000254	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000134	0.000253	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000133	0.000253	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EP300—esophageal cancer	0.000133	0.000251	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP2A6—esophageal cancer	0.000132	0.000251	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDE4D—esophageal cancer	0.000132	0.00025	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.000131	0.000249	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CASP8—esophageal cancer	0.000131	0.000248	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CREBBP—esophageal cancer	0.00013	0.000247	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00013	0.000245	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000127	0.000241	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000127	0.00024	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000126	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GNG7—esophageal cancer	0.000126	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ENO1—esophageal cancer	0.000126	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS1—esophageal cancer	0.000126	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PSME1—esophageal cancer	0.000124	0.000234	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PSME2—esophageal cancer	0.000124	0.000234	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ERBB2—esophageal cancer	0.000124	0.000234	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.000123	0.000234	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000123	0.000233	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000122	0.000231	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.00012	0.000228	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00012	0.000228	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—esophageal cancer	0.00012	0.000228	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2A—esophageal cancer	0.00012	0.000227	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000119	0.000226	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—esophageal cancer	0.000119	0.000225	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—XIAP—esophageal cancer	0.000118	0.000223	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ABL1—esophageal cancer	0.000117	0.000222	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000113	0.000214	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—esophageal cancer	0.000113	0.000214	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—BCL2—esophageal cancer	0.000112	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNA1—esophageal cancer	0.000111	0.000211	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFBR2—esophageal cancer	0.000111	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL2—esophageal cancer	0.000111	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000109	0.000207	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB2—esophageal cancer	0.000109	0.000207	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP1B1—esophageal cancer	0.000107	0.000202	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SMAD4—esophageal cancer	0.000105	0.000199	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000104	0.000197	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PSME1—esophageal cancer	0.000103	0.000196	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PSME2—esophageal cancer	0.000103	0.000196	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ANXA1—esophageal cancer	0.000103	0.000195	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000101	0.000192	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—esophageal cancer	0.000101	0.000192	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EP300—esophageal cancer	0.000101	0.000191	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP19A1—esophageal cancer	0.0001	0.00019	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SST—esophageal cancer	0.0001	0.00019	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.0001	0.000189	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CA—esophageal cancer	9.81e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN1A—esophageal cancer	9.79e-05	0.000185	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH3—esophageal cancer	9.76e-05	0.000185	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GHRL—esophageal cancer	9.76e-05	0.000185	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FBXW7—esophageal cancer	9.6e-05	0.000182	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	9.53e-05	0.00018	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	9.4e-05	0.000178	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CDKN1A—esophageal cancer	9.34e-05	0.000177	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—EP300—esophageal cancer	9.32e-05	0.000176	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—HMOX1—esophageal cancer	9.16e-05	0.000173	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—esophageal cancer	9.08e-05	0.000172	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TLR4—esophageal cancer	8.9e-05	0.000169	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EP300—esophageal cancer	8.89e-05	0.000168	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ABCB1—esophageal cancer	8.79e-05	0.000167	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH2—esophageal cancer	8.76e-05	0.000166	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HIF1A—esophageal cancer	8.59e-05	0.000163	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—esophageal cancer	8.58e-05	0.000162	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.56e-05	0.000162	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—esophageal cancer	8.12e-05	0.000154	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS2—esophageal cancer	7.81e-05	0.000148	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFBR2—esophageal cancer	7.77e-05	0.000147	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOTCH1—esophageal cancer	7.74e-05	0.000147	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CASP8—esophageal cancer	7.63e-05	0.000145	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CREBBP—esophageal cancer	7.6e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—esophageal cancer	7.57e-05	0.000143	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.47e-05	0.000141	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SMAD4—esophageal cancer	7.35e-05	0.000139	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CREBBP—esophageal cancer	7.02e-05	0.000133	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—esophageal cancer	6.67e-05	0.000126	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BLVRB—esophageal cancer	6.63e-05	0.000126	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	6.63e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—esophageal cancer	6.57e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2—esophageal cancer	6.55e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—esophageal cancer	6.36e-05	0.000121	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS3—esophageal cancer	6.28e-05	0.000119	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HIF1A—esophageal cancer	6.02e-05	0.000114	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.93e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CREBBP—esophageal cancer	5.88e-05	0.000111	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—esophageal cancer	5.88e-05	0.000111	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KDR—esophageal cancer	5.75e-05	0.000109	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—esophageal cancer	5.75e-05	0.000109	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	5.64e-05	0.000107	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA1—esophageal cancer	5.64e-05	0.000107	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1A—esophageal cancer	5.44e-05	0.000103	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH1—esophageal cancer	5.42e-05	0.000103	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NOS3—esophageal cancer	5.26e-05	9.96e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EP300—esophageal cancer	5.18e-05	9.8e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA2—esophageal cancer	5.16e-05	9.77e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	5.12e-05	9.7e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BLVRB—esophageal cancer	5.12e-05	9.7e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.04e-05	9.55e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1A—esophageal cancer	5.02e-05	9.51e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CREBBP—esophageal cancer	4.91e-05	9.31e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—esophageal cancer	4.81e-05	9.11e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ADH7—esophageal cancer	4.8e-05	9.08e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLCE1—esophageal cancer	4.8e-05	9.08e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EP300—esophageal cancer	4.78e-05	9.05e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.74e-05	8.98e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—esophageal cancer	4.41e-05	8.35e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOS3—esophageal cancer	4.4e-05	8.33e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA1—esophageal cancer	4.35e-05	8.24e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	4.35e-05	8.24e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ADH1B—esophageal cancer	4.21e-05	7.97e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—esophageal cancer	4.16e-05	7.89e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—esophageal cancer	4.11e-05	7.79e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—esophageal cancer	4.07e-05	7.71e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMP—esophageal cancer	4.02e-05	7.61e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—EP300—esophageal cancer	4e-05	7.58e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA2—esophageal cancer	3.98e-05	7.54e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	3.91e-05	7.4e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—esophageal cancer	3.83e-05	7.25e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALOX15—esophageal cancer	3.81e-05	7.22e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ADH7—esophageal cancer	3.7e-05	7.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.7e-05	7.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—esophageal cancer	3.64e-05	6.89e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TPI1—esophageal cancer	3.64e-05	6.88e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTO1—esophageal cancer	3.64e-05	6.88e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—esophageal cancer	3.54e-05	6.69e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1A—esophageal cancer	3.52e-05	6.66e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDOB—esophageal cancer	3.48e-05	6.6e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GAPDH—esophageal cancer	3.35e-05	6.35e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EP300—esophageal cancer	3.35e-05	6.34e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CRABP1—esophageal cancer	3.32e-05	6.3e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.25e-05	6.15e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GNG7—esophageal cancer	3.16e-05	5.99e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMP—esophageal cancer	3.1e-05	5.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3.02e-05	5.71e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDH2—esophageal cancer	2.96e-05	5.61e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—esophageal cancer	2.96e-05	5.61e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.94e-05	5.57e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—esophageal cancer	2.92e-05	5.52e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—esophageal cancer	2.85e-05	5.4e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.82e-05	5.34e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TPI1—esophageal cancer	2.81e-05	5.31e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.81e-05	5.31e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2.79e-05	5.28e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.78e-05	5.26e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.69e-05	5.09e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS1—esophageal cancer	2.64e-05	5e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENO1—esophageal cancer	2.64e-05	5e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PSME2—esophageal cancer	2.6e-05	4.93e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PSME1—esophageal cancer	2.6e-05	4.93e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.59e-05	4.9e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.57e-05	4.86e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—esophageal cancer	2.48e-05	4.69e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GNG7—esophageal cancer	2.44e-05	4.62e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—esophageal cancer	2.39e-05	4.54e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.29e-05	4.33e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.27e-05	4.3e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.25e-05	4.25e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.18e-05	4.12e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.15e-05	4.07e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.11e-05	4e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENO1—esophageal cancer	2.04e-05	3.86e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.04e-05	3.86e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PSME2—esophageal cancer	2.01e-05	3.8e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PSME1—esophageal cancer	2.01e-05	3.8e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.93e-05	3.65e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.89e-05	3.58e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.85e-05	3.5e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.73e-05	3.28e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.63e-05	3.09e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.49e-05	2.82e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.43e-05	2.7e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.4e-05	2.65e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.24e-05	2.34e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NOS3—esophageal cancer	1.11e-05	2.1e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.01e-05	1.92e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CREBBP—esophageal cancer	9.54e-06	1.81e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NOS3—esophageal cancer	8.54e-06	1.62e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—EP300—esophageal cancer	8.42e-06	1.59e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—esophageal cancer	7.81e-06	1.48e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—EP300—esophageal cancer	6.5e-06	1.23e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	6.23e-06	1.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.81e-06	9.1e-06	CbGpPWpGaD
